MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Vertex and Ribometrix Establish Strategic Collaboration to Discover and Develop RNA-Targeted Small Molecule Therapeutics
Laura TadvalkarSeptember 30, 2019
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Sonde Health Appoints David Liu as CEO

Mari YoshiokaOctober 24, 2019
Next

Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform

Laura TadvalkarSeptember 27, 2019

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact